Combination therapy for the treatment of glioblastoma
US10617755B2 · kind B2 · utility
1Cited by
6References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 27, 2014 |
| Grant date | Apr 14, 2020 |
| Priority date | — |
| Expiry date | Aug 27, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/505
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention concerns methods of treating a patient diagnosed with glioblastoma comprising administering to said patient a therapy comprising an effective amount of an anti-VEGF antibody and a chemotherapeutic.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.